The First AI Drug Prescriber

This Viewpoint explores the entry of AI into clinical care, the role of the US Food and Drug Administration, and the associated legal, public health, and medical implications.

Corresponding Author: Daniel G. Aaron, MD, JD, S.J. Quinney College of Law, University of Utah, 383 S University St, Salt Lake City, UT 84112 (daniel.aaron@law.utah.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.